Anti-Angiogenic Gene Therapy of Malignant Glioma

Acta Neurochirurgica, Supplement

Volumn 1997, Issue 68, 1997, Pages 105-110

  Stratmann, A ^a   Machein, M R ^a   Plate, K H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenic growth factors; Glioblastoma; Tumour angiogenesis; VEGF R2 (flk)

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

ANIMAL; BRAIN TUMOR; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETICS; GLIOBLASTOMA; HUMAN; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RAT; REVIEW; VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOBLASTOMA; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 0030629457     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6513-3_20     Document Type: Article

References (30)

1. Barnard RO (1986) The pathology of brain tumours. In: Beehen NM (ed) Tumours of the brain. Springer, Berlin Heidelberg New York Tokyo, pp 60-70
2. Breier G, Albrecht U, Sterrer S, Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532
3. Cheng SY, Huang HJS, Nagane M, Ji XD, Wang DG, Shih CCY, Arap W, Huang CM, Cavenee WK (1996) Suppression of glioblastoma angiogenicity and tumourigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93: 8502-8507
4. Claffey KP, Brown LF, Delaguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumour growth, angiogenesis, and experimental metastasis. Cancer Res 56: 172-181
5. Conolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J (1989) Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478
6. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991
7. Dumont DJ, Gradwohl G, Fong GH, Pun MC, Gertsenstein M, Auerbach A, Breitman ML (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897-1909
8. Folkman J (1990) What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
9. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
10. Fong GH, Rossant J, Gertsenstein M, Breitman M (1995) Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70
11. Hatva E, Kaipainen A, Mentula P, Jääskeläinen J, Paetau A, Haltia M, Alitalo K (1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumours. Am J Pathol 146: 368-378
12. Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766
13. Kim JB, Li B, Winer J, Armanini M, Gillet N, Philipps HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844
14. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309
15. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller N, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846
16. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367: 576-579
17. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM (1996) Dominant-negative inhibition of flk-1 suppresses the growth of many tumour types in vivo. Cancer Res 56: 1615-1620
18. Partanen J, Armstrong E, Mäkelä TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K (1992) A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12: 1698-1707
19. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-847
20. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res 53: 5822-5827
21. Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumour angiogenesis. Brain Pathol 4: 207-218
22. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529
23. Plate KH, Risau W (1995) Angiogenesis in malignant gliomas. Glia 15: 339-347
24. Rak JW, St Croix BD, Kerbel RS (1995) Consequences of angiogenesis for tumour progression, metastasis and cancer therapy. Anticancer Drugs 6: 3-18
25. Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401
26. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Quin Y (1995) Distinct roles of the receptor tyrosine kinases tie-1 and tie-2 in blood vessel formation. Nature 376: 70-74
27. Schnürch H, Risau W (1993) Expression of tie-2, a member of novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119: 957-968
28. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature 376: 62-66
29. Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK (1996) Flk-1 as a target for tumour growth inhibition. Cancer Res 56: 3540-3545
30. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz C, Böhlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187: 1579-1586